Actions

US stocks fluctuate as tech gains offset losses; SMI pares declines
Dow futures edge higher while Nasdaq 100 slips; energy price surge fuels inflation concerns ahead of Fed decision. Swiss market pares losses with defensive stocks leading gains.

DAX extends losses as oil prices and bond yields rise
German blue-chip index falls 0.44% to 25,856 amid elevated oil prices and bond yields, while MDax declines 1.04%. Geopolitical tensions in the Middle East further support crude prices.

Credit Exchange CEO on scaling Swiss mortgage platform to $6 bln
Serkan Mirza discusses leading the Credit Exchange’s rapid growth, integrating AI and expanding into pensions as the B2B platform reshapes Switzerland’s mortgage market.

Morgan Stanley lifts ratings on Coloplast, Demant in European MedTech
Analysts raise targets on hearing-aid names and rebalance coverage after strategic updates, while downgrading Smith & Nephew to equal weight. Sector remains in-line.

DAX inclusion shows mixed long-term stock performance gains
Deutsche Bank analysis finds new DAX entrants underperform the index by a median 8% in their first year, despite short-term liquidity boosts. Changes effective September 21.

Swiss stocks slip as oil, rate fears weigh on markets
SMI falls 0.4% as Brent crude tops $95, inflation and ECB/Fed policy expectations drive defensive rotation; Roche, Swiss Life gain while Amrize, Holcim lag.

Nvidia lifts US tech as Salesforce jumps; SMI hits session low
Nvidia surged 8% premarket after strong outlook, lifting the Nasdaq 100, while Salesforce rallied 10% on AI-driven growth guidance. Swiss equities fell 1.2% as heavyweights weighed.

Swiss equities slip as oil, inflation and rate fears weigh
SMI falls 0.4% to 14,280 as defensive shares lag; Amrize drops 2.7% after BofA downgrade, Roche and Swiss Life advance. Brent crude tops $95/bbl after U.S.-Iran strikes.

US stocks slip at week open as oil spikes, geopolitics weigh
Dow Jones falls 0.4% as Brent crude tops $91; Aon shares drop on $17bn KKR deal; GameStop warns on Q2 revenue amid store closures.

Swiss stocks fall as oil surge fuels inflation concerns; UBS upgrades Comet, VAT, Inficon
SMI drops 0.1% as Brent crude tops $95 a barrel after U.S.-Iran tensions escalate; UBS lifts targets on Swiss tech names. Nestlé to sell vitamins unit for $1 billion.

Swiss stocks slip as oil surges, geopolitical risks weigh on markets
The SMI fell 0.1% to 14,323 as Brent crude topped $95 a barrel amid U.S.-Iran tensions. Tech shares led gainers, while Amrize and Partners Group lagged.

Nvidia’s strong results lift Swiss chip suppliers modestly amid mixed market signals
Comet, Inficon and VAT Group gain 1.4%-2.1% after Nvidia’s Q2 revenue surge, but broader semiconductor volatility remains subdued. Analysts cite solid fundamentals for VAT as Citigroup sets a 850-franc target.

Nvidia lifts premarket U.S. stocks; Salesforce surges on outlook; SMI falls
U.S. futures rise as Nvidia’s results fuel AI optimism; Salesforce jumps 10% on raised revenue guidance. Swiss SMI declines 0.9% as heavyweights Nestlé, Novartis and Roche weigh.

US tech shares rise on Nvidia rally; Swiss SMI falls on heavyweights
Nasdaq 100 gains 1% as Nvidia soars 7.3% on AI demand; S&P 500 up 0.46%; HP drops 6% on weak outlook; Swiss SMI down 1.2% as heavyweights weigh.

Novartis shares hit record high on multiple sclerosis drug data
Swiss pharma giant rallies 6.3% after positive late-stage trial results for oral multiple sclerosis drug Remibrutinib, outpacing broader market slump. Analysts flag upside potential but warn of near-term consolidation risks.

Investis reports 6.8% rise in H1 rental income, LTV falls to 27.3%
Swiss real estate firm posts CHF 41.5 million in rental income for the half-year, while loan-to-value ratio declines to 27.3%. Portfolio value reaches CHF 2.3 billion.

European stocks fall despite Nvidia gains as Jackson Hole looms
Euro Stoxx 50, FTSE 100 and SMI decline after Nvidia's strong outlook fails to lift broader European equities. Tech sector buoys gains while defensive stocks weigh on Swiss index.

German DAX falls 1.1% as oil prices rise, inflation fears weigh
September opens with losses for Europe's benchmark index as geopolitical tensions lift oil prices and investors reassess rate expectations. Euro Stoxx 50 also declines.

Swiss pharma midcaps Basilea, Siegfried draw value investor interest
Basilea and Siegfried offer discounted valuations, earnings upgrades and growth prospects as Swiss pharma sector outperformers. Analysts set 38% and 55% upside targets respectively.

Euro Stoxx 50 falls 0.8% as oil prices rise amid Iran tensions
Eurozone benchmark index extends losses to August lows as geopolitical risks and energy prices drive inflation concerns ahead of ECB meeting. Swiss SMI rises 0.34%, FTSE 100 dips 0.32%.

Feintool swings to profit in H1 2026 on strong demand
Swiss automotive supplier posts 5.6% revenue growth to CHF 353.3m, EBITDA up 47% to CHF 34.1m as regional demand diverges.

European stocks rise on Fed hawkish signals ahead of U.S. rate decision
Euro Stoxx 50 gains 0.95% as investors price in potential September Fed hike; FTSE 100 and SMI also advance. Warsh signals readiness for tighter policy amid persistent inflation concerns.

VW’s Blume pushes cost cuts as Niedersachsen seeks compromise
Volkswagen’s CEO urges sweeping savings ahead of a pivotal supervisory board meeting on Sept. 4, while Germany’s Lower Saxony seeks consensus amid competing restructuring plans.

Investis reports 6.8% rental income rise in H1 2026 despite stock dip
Swiss real estate firm posts CHF 41.5 million rental income growth in first half, while shares slip 1.35% as market conditions tighten. Portfolio value nears CHF 2.3 billion.

